跳至主要内容
临床试验/CTRI/2017/06/008943
CTRI/2017/06/008943尚未招募4 期

Comparison between intravenous hydralazine versus labetalol in managing severe pregnancy induced hypertension â?? a Tertiary care study - HLPIH

College of Medicine and JNM Hospital West Bengal University of Health Sciences Kalyani0 个研究点目标入组 113 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
113

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Pregnancy more than 20weeks and
  • Severe Pregnancy Induced Hypertension (systolic blood pressure of 160mmHg or more and /or diastolic blood pressure of 110mmHg or more)

排除标准

  • Pregnancy beyond less than 20 weeks gestational age
  • Who do not agree for consent.
  • Contraindication or known allergy to hydralazine or labetalol

研究者

发起方
College of Medicine and JNM Hospital West Bengal University of Health Sciences Kalyani

相似试验